BR31: A phase 3, double blind, placebo controlled, randomised trial of adjuvant durvalumab in completely resected non-small cell lung cancer

被引：0
|
作者：
McLachlan, Sue-Anne [1 ,2 ]
Mersiades, Antony [3 ]
Wright, Gavin [4 ]
Millward, Michael [5 ]
Goss, Glenwood [6 ]
Darling, Gail [7 ,8 ]
Jurkovic, Hannora [3 ]
Bradley, Ann-Marie [9 ]
Pavlakis, Nick [10 ]
Blinman, Prunella [11 ,12 ]
Ding, Keyue [13 ]
O'Callaghan, Chris [9 ,14 ]
Stockler, Martin [3 ]
机构：
[1] St Vincents Hosp, Dept Med Oncol, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[4] St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia
[5] Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia
[6] Ottawa Hosp, Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada
[7] Toronto Gen Hosp, Univ Hlth Network, Div Thorac Surg, Dept Surg, Toronto, ON, Canada
[8] Univ Toronto, Toronto, ON, Canada
[9] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
[10] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia
[11] Concord Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia
[12] Univ Sydney, Sydney, NSW, Australia
[13] Queens Univ, Canc Res Inst, Canadian Canc Trials Grp, Kingston, ON, Canada
[14] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
419
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [1] CCTG BR.31: A global, double-blind placebo-controlled, randomized phase III study of adjuvant durvalumab in completely resected non-small cell lung cancer (NSCLC)
    Goss, G.
    Darling, G. E.
    Westeel, V.
    Nakagawa, K.
    Massuti Sureda, B.
    Perrone, F.
    McLachlan, S-A.
    Kang, J. H.
    Wu, Y-L.
    Dingemans, A-M. C.
    Dziadziuszko, R.
    Okada, M.
    Greillier, L.
    Audigier-Valette, C.
    Sugawara, S.
    Nadal, E.
    Catino, A.
    Stockler, M. R.
    Ding, K.
    O'Callaghan, C.
    ANNALS OF ONCOLOGY, 2024, 35 : 1238 - 1238
  • [2] Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
    Pirker, Robert
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (05) : 305 - 310
  • [3] Compliance with adjuvant chemotherapy for completely resected non-small cell lung cancer
    Lee, Hyun-Sung
    Kim, Moon Soo
    Lee, Jong Mog
    Kim, Heung Tae
    Zo, Jae Ill
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S480 - S480
  • [4] CANOPY-A: A phase III, multicenter, randomized, double-blind, placebo-controlled trial evaluating canakinumab as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC).
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    De Marchi, Pedro
    Goto, Yasushi
    Kowalski, Dariusz M.
    Lu, Shun
    Paz-Ares, Luis G.
    Spigel, David R.
    Spira, Alexander, I
    Thomas, Michael
    Leung, Mimi
    Baum, Jason
    Zhu, Zewen
    Oliveira Portella, Maria do Socorro
    Yang, James Chih-Hsin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC)
    Lee Siow-Ming
    Woll, Penella J.
    Rudd, Robin M.
    Gower, Nicole H.
    Ottensmeier, Christian H.
    Ali, Kulsam
    Spiro, Stephen G.
    Hackshaw, Allan
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S359 - S359
  • [6] Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review
    Alam, Naveed
    Darling, Gail
    Evans, William K.
    Mackay, Jean A.
    Shepherd, Frances A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (02) : 146 - 155
  • [7] Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small Cell Lung Cancer: CANOPY-A Trial
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    De Marchi, Pedro
    Goto, Yasushi
    Kowalski, Dariusz
    Lu, Shun
    Spigel, David R.
    Thomas, Michael
    Yang, James Chih-Hsin
    Turri, Sabine
    Zhou, Wen
    Kreisl, Teri
    Paz-Ares, Luis
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [8] Canakinumab as Adjuvant Therapy in Patients with Completely Resected Non-Small Cell Lung Cancer: CANOPY-A Trial
    Spira, A.
    Ardizzoni, A.
    Barlesi, F.
    Cho, B.
    de Marchi, P.
    Goto, Y.
    Kowalski, D.
    Lu, S.
    Paz-Ares, L.
    Spigel, D.
    Thomas, M.
    Turri, S.
    Rodrik-Outmezguine, V.
    Zhou, W.
    Kreisl, T.
    Yang, J.
    Garon, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
    Shuji Murakami
    Haruhiro Saito
    Tetsuro Kondo
    Hiroyuki Ito
    Fumihiro Oshita
    Kouzo Yamada
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 81 - 87
  • [10] Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
    Murakami, Shuji
    Saito, Haruhiro
    Kondo, Tetsuro
    Ito, Hiroyuki
    Oshita, Fumihiro
    Yamada, Kouzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 81 - 87
12345